DK0640350T3 - Keramiske partikler og fremstilling deraf - Google Patents

Keramiske partikler og fremstilling deraf

Info

Publication number
DK0640350T3
DK0640350T3 DK94116972T DK94116972T DK0640350T3 DK 0640350 T3 DK0640350 T3 DK 0640350T3 DK 94116972 T DK94116972 T DK 94116972T DK 94116972 T DK94116972 T DK 94116972T DK 0640350 T3 DK0640350 T3 DK 0640350T3
Authority
DK
Denmark
Prior art keywords
preparation
ceramic particles
ceramic
particles
Prior art date
Application number
DK94116972T
Other languages
Danish (da)
English (en)
Inventor
Aaron Gershon Filler
Andrew Michael Lindsay Lever
Original Assignee
Syngenix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenix Ltd filed Critical Syngenix Ltd
Application granted granted Critical
Publication of DK0640350T3 publication Critical patent/DK0640350T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94116972T 1991-09-16 1992-09-16 Keramiske partikler og fremstilling deraf DK0640350T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119762A GB9119762D0 (en) 1991-09-16 1991-09-16 Particulate agents for nmt

Publications (1)

Publication Number Publication Date
DK0640350T3 true DK0640350T3 (da) 2002-08-05

Family

ID=10701480

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94116972T DK0640350T3 (da) 1991-09-16 1992-09-16 Keramiske partikler og fremstilling deraf

Country Status (10)

Country Link
US (2) US6153598A (de)
EP (2) EP0610232A1 (de)
JP (1) JP3560969B2 (de)
AU (1) AU669128B2 (de)
CA (1) CA2119145C (de)
DE (1) DE69232547T2 (de)
DK (1) DK0640350T3 (de)
ES (1) ES2176216T3 (de)
GB (1) GB9119762D0 (de)
WO (1) WO1993005815A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
GB9119762D0 (en) * 1991-09-16 1991-10-30 Filler Aaron G Particulate agents for nmt
GB2282139A (en) * 1993-09-24 1995-03-29 Univ Reading Introducing DNA into the germ line of birds
US5534423A (en) * 1993-10-08 1996-07-09 Regents Of The University Of Michigan Methods of increasing rates of infection by directing motion of vectors
US5811274A (en) * 1994-12-09 1998-09-22 The Regents Of The University Of Michigan Methods, compositions and apparatus for cell transfection
WO1996040273A2 (en) * 1995-06-07 1996-12-19 Schering Aktiengesellschaft Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures
AU1194697A (en) * 1995-12-21 1997-07-17 Quest International B.V. Particle compositions
FR2762615B1 (fr) 1997-04-28 1999-07-16 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes et vecteur le contenant
US6372722B1 (en) * 2000-01-19 2002-04-16 Genteric, Inc. Method for nucleic acid transfection of cells
EP1297169B1 (de) * 2000-06-26 2012-08-08 Ethris Gmbh Verfahren zur zelltransfektion mittels eines magnetischen feldes
WO2002103004A1 (en) * 2001-06-15 2002-12-27 The Children's Hospital Of Philadelphia Surface modification for improving biocompatibility
AU2002324193A1 (en) * 2001-09-13 2003-03-24 Scientific Generics Limited Therapeutic insert and therapeutic method
WO2003037302A1 (en) * 2001-10-30 2003-05-08 Windsor J Brian Method and system for the co-isolation of cognate dna, rna and protein sequences and method for screening co-isolates for defined activities
US20040063158A1 (en) * 2002-09-26 2004-04-01 Ivan Alferiev Method of determining surface binding capacity
JP2007511625A (ja) * 2003-10-29 2007-05-10 フイルメニツヒ　ソシエテ　アノニム 無機物ナノ粒子に基づく香料送達系
US20060263898A1 (en) * 2003-10-29 2006-11-23 Walter Paget Perfume delivery systems based on inorganic nano particles
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
DE3019764A1 (de) * 1980-05-23 1981-12-03 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von synthetischem lepidokrokit
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4826823A (en) 1985-02-05 1989-05-02 Warner-Lambert Company Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
SE8704157L (sv) * 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning
GB2221466A (en) * 1988-03-09 1990-02-07 Aluminum Co Of America Biologically reactive particles with biological, therapeutic and chromatographic applications
AU8514291A (en) * 1990-09-14 1992-04-15 St. George's Enterprises Limited Particulate agents
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
JPH06503714A (ja) * 1990-09-25 1994-04-28 ユニバーシティ オブ コネチカット 細胞内に導入されたポリヌクレオチドの長時間発現
CA2097589C (en) * 1990-12-19 1998-05-05 Lee Josephson Targeting of therapeutic agents using polysaccharides
JPH06504274A (ja) * 1991-01-07 1994-05-19 シンジェニックス・リミテッド 微細粒子
GB9119762D0 (en) * 1991-09-16 1991-10-30 Filler Aaron G Particulate agents for nmt

Also Published As

Publication number Publication date
EP0640350A3 (de) 1995-12-13
AU2567992A (en) 1993-04-27
EP0610232A1 (de) 1994-08-17
EP0640350A2 (de) 1995-03-01
AU669128B2 (en) 1996-05-30
US6153598A (en) 2000-11-28
WO1993005815A1 (en) 1993-04-01
ES2176216T3 (es) 2002-12-01
JPH07501793A (ja) 1995-02-23
US20020123478A1 (en) 2002-09-05
GB9119762D0 (en) 1991-10-30
JP3560969B2 (ja) 2004-09-02
EP0640350B1 (de) 2002-04-10
US6809082B2 (en) 2004-10-26
CA2119145C (en) 2003-11-25
CA2119145A1 (en) 1993-04-01
DE69232547D1 (de) 2002-05-16
DE69232547T2 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
DK0528201T3 (da) Ensartede uorganiske mikrosfærer og fremstilling deraf
FI88440B (fi) Keramiskt filter
DK1023900T3 (da) Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
DK527789D0 (da) Dithiocarbamoylquinoloner og sammensaetninger omfattende samme
DK0640350T3 (da) Keramiske partikler og fremstilling deraf
NO930118D0 (no) Scintillator og fremstilling derav
NO933611D0 (no) Anti-tumor- og anti-psoriatiske midler
DK0579741T3 (da) Insekticidt præparat og insekticide enheder
GB9119239D0 (en) Ceramic particles
DK246189A (da) Antimikrobielt praeparat og anvendelse deraf
DE69227564D1 (de) Nachlauf spreizungskompensiert und Sturz nachlaufkompensiert
IL100394A0 (en) Polysilazanes and their preparation
DK564189D0 (da) Insecticidt praeparat og insecticid aerosol
DE69216896D1 (de) Keramisches Filter
DK0456138T3 (da) Peptidamidaser og anvendelse deraf
DK501989D0 (da) Mikrobiocidt praeparat og dettes fremstilling
NO900129D0 (no) Keramikkfilter og fremstilling av dette.
BR9205281A (pt) Pentapeptideos imuno-reguladores e neuro-reguladores
DK410089A (da) Substituerede phenylalkylthiophener og dens fremstilling
DK0508734T3 (da) Keramisk filter
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
DK36390D0 (da) Forbindelser og anvendelse
DK8590D0 (da) Forbindelser og anvendelse